While Cg Oncology Inc has underperformed by -1.27%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CGON rose by 30.30%, with highs and lows ranging from $46.01 to $14.80, whereas the simple moving average jumped by 21.41% in the last 200 days.
On December 11, 2025, Wedbush started tracking Cg Oncology Inc (NASDAQ: CGON) recommending Outperform. A report published by Truist on November 24, 2025, Initiated its previous ‘Buy’ rating for CGON. Guggenheim also rated CGON shares as ‘Buy’, setting a target price of $90 on the company’s shares in an initiating report dated October 08, 2025. Piper Sandler Initiated an Overweight rating on August 19, 2025, and assigned a price target of $55. Goldman initiated its ‘Buy’ rating for CGON, as published in its report on July 10, 2025. JP Morgan’s report from May 02, 2025 suggests a price prediction of $41 for CGON shares, giving the stock a ‘Overweight’ rating. Scotiabank also rated the stock as ‘Sector Perform’.
Analysis of Cg Oncology Inc (CGON)
Further, the quarter-over-quarter increase in sales is 3774.42%, showing a positive trend in the upcoming months.
Cg Oncology Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -24.74% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 22.74, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and CGON has an average volume of 916.40K. On a monthly basis, the volatility of the stock is set at 5.48%, whereas on a weekly basis, it is put at 4.51%, with a loss of -10.47% over the past seven days. Furthermore, long-term investors anticipate a median target price of $70.71, showing growth from the present price of $37.37, which can serve as yet another indication of whether CGON is worth investing in or should be passed over.
How Do You Analyze Cg Oncology Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 37.18%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 76.88% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
